News and Updates

A historical account about a past initiative that would help pave the way for Breakthrough T1D’s future approach to identifying research priorities.

Becky Lois, Ph.D., discussed how parents can help children cope with the psychosocial challenges of living with T1D during quarantine.

Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.

ViaCyte, a regenerative medicine company long-supported by Breakthrough T1D, today announced $27 million in financing to continue the development of beta cell therapies for diabetes. This funding ensures that Viacyte’s innovative approaches to replacing the insulin-producing beta cells in people with type 1 diabetes (T1D) will keep progressing. “Beta cell therapies are a key component […]

Breakthrough T1D welcomes the May 26th announcement by the Centers for Medicare & Medicaid Services about more affordable insulin options for people in the Medicare program.

Virtual Visits Can Transform Care and Improve Outcomes for People with T1D

The American Diabetes Association’s (ADA) 80th Scientific Sessions is almost here! From June 12-16, scientists and healthcare professionals will gather, virtually, at one of the largest conferences of diabetes researchers in the world. Breakthrough T1D-funded researchers will also be there virtually to hear first-hand and present new study results that will improve outcomes for people […]

Mask-making family raised more than $26,000 for Denver Breakthrough T1D One Walk.

Author and T1D mom Moira McCarthy shares the secrets to having a family that thrives even after a family member has been diagnosed.

During a recent Breakthrough T1D Facebook Live event, a panel of leaders discussed Medtronic’s efforts to support the T1D community during the pandemic.